Velvio GmbH
PrivateCompany Overview
Velvio GmbH is a biotechnology company that develops antisense oligonucleotide compounds to restore organ repair functions as a treatment for orphan diseases in neurodegeneration, including amyotrophic lateral sclerosis (ALS) and idiopathic pulmonary fibrosis (IPF).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Velvio GmbH Comparables
Compare Velvio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Neuroscience | 81% | |
| SynaptixBio | 81% | |
| QurAlis | 78% | |
Velvio GmbH Funding Rounds
Historical fundraising activity
Velvio GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Velvio GmbH's valuation, stock price, and market status.